Medication beliefs and structural barriers to treatment adherence among people living with HIV infection

被引:34
作者
Kalichman, Seth [1 ]
Kalichman, Moira O. [1 ]
Cherry, Chauncey [1 ]
机构
[1] Univ Connecticut, Dept Psychol, Storrs, CT USA
关键词
HIV-AIDS; medication adherence; poverty; medicines necessity-concerns beliefs; structural barriers; ANTIRETROVIRAL THERAPY; ALCOHOL-USE; MEDICINES; MEN; PERCEPTIONS; POPULATION; DEPRESSION; DISORDERS; TELEPHONE; SYMPTOMS;
D O I
10.1080/08870446.2015.1111371
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: People living in poverty face multiple structural challenges to medication adherence including lack of transportation, inadequate housing and food insecurity. The degree to which individuals' motivations to remain adherent may overcome structural barriers has received limited attention. Purpose: To examine whether medication necessity and concerns beliefs predict antiretroviral therapy (ART) adherence over and above structural adherence barriers associated with poverty. Methods: People living with HIV in a southern US city (N=942) completed computerised interviews, an objective measure of adherence and HIV viral suppression obtained from medical records. Hierarchical logistic regression models were constructed to examine demographic and illness characteristics, structural barriers, mental health, substance use and medication necessity and concerns beliefs as predictors of ART adherence. Results: In multivariable models, current drug use and medication necessity and concerns beliefs predicted treatment adherence over and above demographic, health, mental health and structural factors. Conclusions: Medication beliefs are proximal and powerful motivating factors that predict adherence. Adherence interventions should directly address medication beliefs in developing strategies to manage barriers facing people with HIV living in poverty.
引用
收藏
页码:383 / 395
页数:13
相关论文
共 38 条
[1]  
Bangsberg D.R., 2001, AIDS BEHAV, V5, P275, DOI [DOI 10.1023/A:1011396711486, https://doi.org/10.1023/A:1011396711486]
[2]   Adherence-resistance relationships to combination HIV antiretroviral therapy [J].
Bangsberg D.R. ;
Kroetz D.L. ;
Deeks S.G. .
Current HIV/AIDS Reports, 2007, 4 (2) :65-72
[3]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[4]   Is average adherence to HIV antiretroviral therapy enough? [J].
Bangsberg, DR ;
Deeks, SG .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (10) :812-813
[5]   Self-reported side-effects of anti-retroviral treatment among IDUs: A 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8) [J].
Carrieri, Maria Patrizia ;
Villes, Virginie ;
Raffi, Francois ;
Protopopescu, Camelia ;
Preau, Marie ;
Salmon, Dominique ;
Taieb, Audrey ;
Lang, Jean-Marie ;
Verdon, Renaud ;
Chene, Genevieve ;
Spire, Bruno .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2007, 18 (04) :288-295
[6]   Coping effectiveness training for men living with HIV: Preliminary findings [J].
Chesney, M ;
Folkman, S ;
Chambers, D .
INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 :75-82
[7]   Patient-centred advice is effective in improving adherence to medicines [J].
Clifford, Sarah ;
Barber, Nick ;
Elliott, Rachel ;
Hartley, Elaine ;
Horne, Rob .
PHARMACY WORLD & SCIENCE, 2006, 28 (03) :165-170
[8]   Food security, poverty, and human development in the United States [J].
Cook, John T. ;
Frank, Deborah A. .
REDUCING THE IMPACT OF POVERTY ON HEALTH AND HUMAN DEVELOPMENT: SCIENTIFIC APPROACHES, 2008, 1136 :193-209
[9]   An information-motivation-behavioral skills model of adherence to antiretroviral therapy [J].
Fisher, Jeffrey D. ;
Fisher, William A. ;
Amico, K. Rivet ;
Harman, Jennifer J. .
HEALTH PSYCHOLOGY, 2006, 25 (04) :462-473
[10]   The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection [J].
Gardner, Edward M. ;
McLees, Margaret P. ;
Steiner, John F. ;
del Rio, Carlos ;
Burman, William J. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (06) :793-800